Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
8.87
-0.38 (-4.11%)
At close: Sep 4, 2026, 4:00 PM EDT
8.93
+0.06 (0.68%)
After-hours: Sep 4, 2026, 4:47 PM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $12.44 million as of September 4, 2026. Its market cap has decreased by -57.12% in one year.
Market Cap
12.44M
Enterprise Value
273.55K
1-Year Change
-57.12%
Ranking
Category
Stock Price
$8.87
ChartMarket Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.64M to $12.44M, a decrease of -96.44%. That is a compound annual growth rate of -53.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 12.44M | -12.24% |
| Dec 31, 2025 | 14.18M | -84.12% |
| Dec 18, 2024 | 89.29M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.15M | 5.86% |
| Apr 11, 2022 | 349.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Intensity Therapeutics | 13.42M |
| SeaStar Medical Holding | 13.00M |
| Phio Pharmaceuticals | 12.55M |
| PDS Biotechnology | 12.37M |
| BioLineRx | 12.19M |
| AEON Biopharma | 12.17M |
| FibroBiologics | 11.85M |
| IN8bio | 11.63M |